-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.4014.29% Upside
CTI BioPharma Corp. Frequently Asked Questions
-
What analysts cover CTI BioPharma Corp.?
CTI BioPharma Corp. has been rated by research analysts at Jefferies, JMP Securities, Needham, DNB Markets, BTIG in the past 90 days.